691 related articles for article (PubMed ID: 11922728)
1. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Dupuytren's disease fibroblast populated collagen lattice contraction is independent of endogenous active TGF-beta2.
Tse R; Howard J; Wu Y; Gan BS
BMC Musculoskelet Disord; 2004 Nov; 5(1):41. PubMed ID: 15541177
[TBL] [Abstract][Full Text] [Related]
3. Cytokine manipulation of explanted Dupuytren's affected human palmar fascia.
Kuhn MA; Payne WG; Kierney PC; Pu LL; Smith PD; Siegler K; Ko F; Wang X; Robson MC
Int J Surg Investig; 2001; 2(6):443-56. PubMed ID: 12678125
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta1 stimulation enhances Dupuytren's fibroblast contraction in response to uniaxial mechanical load within a 3-dimensional collagen gel.
Bisson MA; Beckett KS; McGrouther DA; Grobbelaar AO; Mudera V
J Hand Surg Am; 2009; 34(6):1102-10. PubMed ID: 19505772
[TBL] [Abstract][Full Text] [Related]
5. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
[TBL] [Abstract][Full Text] [Related]
6. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
Tomasek J; Rayan GM
J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
[TBL] [Abstract][Full Text] [Related]
7. Gene expression analysis of Dupuytren's disease: the role of TGF-beta2.
Zhang AY; Fong KD; Pham H; Nacamuli RP; Longaker MT; Chang J
J Hand Surg Eur Vol; 2008 Dec; 33(6):783-90. PubMed ID: 18694919
[TBL] [Abstract][Full Text] [Related]
8. Down-regulating causes of fibrosis with tamoxifen: a possible cellular/molecular approach to treat rhinophyma.
Payne WG; Ko F; Anspaugh S; Wheeler CK; Wright TE; Robson MC
Ann Plast Surg; 2006 Mar; 56(3):301-5. PubMed ID: 16508362
[TBL] [Abstract][Full Text] [Related]
9. Silicone sheeting decreases fibroblast activity and downregulates TGFbeta2 in hypertrophic scar model.
Kuhn MA; Moffit MR; Smith PD; Lyle WG; Ko F; Meltzer DD; Robson MC
Int J Surg Investig; 2001; 2(6):467-74. PubMed ID: 12678127
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.
Ulrich D; Ulrich F; Piatkowski A; Pallua N
Arch Orthop Trauma Surg; 2009 Nov; 129(11):1453-9. PubMed ID: 18758795
[TBL] [Abstract][Full Text] [Related]
11. An insight into Dupuytren's contracture.
Murrell GA
Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255
[TBL] [Abstract][Full Text] [Related]
12. Investigating the effects of Pirfenidone on TGF-β1 stimulated non-SMAD signaling pathways in Dupuytren's disease -derived fibroblasts.
Zhou C; Zeldin Y; Baratz ME; Kathju S; Satish L
BMC Musculoskelet Disord; 2019 Mar; 20(1):135. PubMed ID: 30927912
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptors in Dupuytren's contracture.
Pagnotta A; Specchia N; Greco F
J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
[TBL] [Abstract][Full Text] [Related]
14. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
Zhou C; Liu F; Gallo PH; Baratz ME; Kathju S; Satish L
BMC Musculoskelet Disord; 2016 Nov; 17(1):469. PubMed ID: 27835939
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic regulation of Dupuytren's fibroblast contraction in vitro.
Rayan GM; Parizi M; Tomasek JJ
J Hand Surg Am; 1996 Nov; 21(6):1065-70. PubMed ID: 8969433
[TBL] [Abstract][Full Text] [Related]
16. Feedback inhibition of high TGF-beta1 concentrations on myofibroblast induction and contraction by Dupuytren's fibroblasts.
Wong M; Mudera V
J Hand Surg Br; 2006 Oct; 31(5):473-83. PubMed ID: 16875762
[TBL] [Abstract][Full Text] [Related]
17. The role of the fibroblast in Dupuytren's contracture.
Murrell GA
Hand Clin; 1991 Nov; 7(4):669-80; discussion 681. PubMed ID: 1769989
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase inhibition reduces contraction by dupuytren fibroblasts.
Townley WA; Cambrey AD; Khaw PT; Grobbelaar AO
J Hand Surg Am; 2008 Nov; 33(9):1608-16. PubMed ID: 18984345
[TBL] [Abstract][Full Text] [Related]
19. Is Dupuytren's disease caused by an imbalance between proliferation and cell death?
Jemec B; Grobbelaar AO; Wilson GD; Smith PJ; Sanders R; McGrouther DA
J Hand Surg Br; 1999 Oct; 24(5):511-4. PubMed ID: 10597921
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta2 activates proliferative scar fibroblasts.
Smith P; Mosiello G; Deluca L; Ko F; Maggi S; Robson MC
J Surg Res; 1999 Apr; 82(2):319-23. PubMed ID: 10090846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
